Drug-Induced Parkinsonism and Neuroleptic Malignant Syndrome: A Case Report
International Journal of Biomedicine · 2020
DOI: 10.21103/article10(2)_cr ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Biomedicine, 2020. Verfasst von Alexey Tappakhov und 6 weiteren Autor:innen.
Abstract (Originalsprache)
The article presents a clinical case of neuroleptic malignant syndrome (NMS) and drug-induced parkinsonism after a single dose of thiorizadine, and discusses the issues of differential diagnosis and treatment methods.A 57-year-old patient with long-term remission of schizophrenia due to insomnia was prescribed thiorizadine.After a single dose, symptoms of parkinsonism in the form of hypokinesia, muscle rigidity and bradyphrenia developed and began to progress.Three weeks later NMS developed, and treatment was carried out in the intensive care unit.When signs of parkinsonism persisted, she was hospitalized in the neurological department.Regression of symptoms occurred by her taking amantadine sulfate.(International Journal of Biomedicine.2020;10(2):174-177.)
Zitieren
APA
Tappakhov, A., Popova, T., Khabarova, Y., Yakovleva, M., Adamova, A., Govorova, T., & Andreev, M. (2020). Drug-Induced Parkinsonism and Neuroleptic Malignant Syndrome: A Case Report. International Journal of Biomedicine. https://doi.org/10.21103/article10(2)_cr
Vancouver
Tappakhov A, Popova T, Khabarova Y, Yakovleva M, Adamova A, Govorova T, et al. Drug-Induced Parkinsonism and Neuroleptic Malignant Syndrome: A Case Report. International Journal of Biomedicine. 2020. doi:10.21103/article10(2)_cr
BibTeX
@article{Tappakhov2020,
author = {Tappakhov, Alexey and Popova, Tatiana and Khabarova, Yulia and Yakovleva, Maria and Adamova, Alina and Govorova, Tatiana and Andreev, Michil},
title = {Drug-Induced Parkinsonism and Neuroleptic Malignant Syndrome: A Case Report},
journal = {International Journal of Biomedicine},
year = {2020},
doi = {10.21103/article10(2)_cr}
}
EUVIMED